Société Générale — M&A Activity 2021

Jul 12, 2021

National Storage Mechanism | Additional information

RNS Number : 8851E

Societe Generale SA

12 July 2021

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1)	Société Générale S.A.
Company dealt in	UDG Healthcare plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	€0.05 ordinary shares
Date of dealing	09/07/2021

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
Number	(%)	Number	(%)
(1) Relevant securities	17,382,906	6.90	11,987	0.00
(2) Derivatives (other than options)	0	0.00	11,218,405	4.45
(3) Options and agreements to purchase/sell	0	0.00	0	0.00
Total	17,382,906	6.90	11,230,392	4.46

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit GBP (Note 5)
Purchase	1,785	10.73
Purchase	274	10.74
Purchase	7	10.73
Purchase	300	10.73
Purchase	1,319	10.74
Purchase	3,934	10.74
Purchase	300	10.74
Purchase	269	10.73
Purchase	222	10.73
Purchase	341	10.74
Purchase	300	10.74
Purchase	1,157	10.74
Purchase	300	10.73
Purchase	515	10.74
Purchase	300	10.74
Purchase	521	10.73
Purchase	35,355	10.74
Purchase	13,312	10.74
Purchase	285	10.72
Purchase	245	10.72
Purchase	291	10.73
Purchase	294	10.73
Purchase	256	10.72
Purchase	375	10.73
Purchase	296	10.73
Purchase	296	10.73
Purchase	311	10.73
Purchase	295	10.73
Purchase	298	10.73
Purchase	334	10.72
Purchase	12,493	10.73
Purchase	2,360	10.73
Purchase	10,147	10.73
Sale	195	10.73
Sale	26	10.73
Sale	7,160	10.74
Sale	3,350	10.74
Sale	4,095	10.74
Sale	1,382	10.74
Sale	23	10.73
Sale	205	10.73
Sale	701	10.74
Sale	150	10.73
Sale	120	10.73
Sale	19	10.73
Sale	1	10.73
Sale	1	10.73
Total Purchases	89,087
Total Sales	17,428

Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit GBP (Note 5)
CFD	Closed long	48,667	10.74
CFD	Increased short	25,000	10.7326825

(b)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(c)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements, or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative

referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure	12/07/2021
Contact name	Société Générale - Disclosure team
Telephone number	+33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEEASXAFDDFEEA